Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Inozyme Pharma Inc
INZYCurrent price
1.01 USD
0 USD (0.00%)
Last closed
0.97 USD
Company
www.inozyme.com
ISIN
US45790W1080
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
194 647 760 USD
Yield for 12 month
-83.79 %
1Y
3Y
5Y
10Y
15Y
INZY
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 321 Summer Street, Boston, MA, United States, 02210
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.56 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-1 294 000 USD
Last Year
-1 177 000 USD
Current Quarter
-195 000 USD
Last Quarter
-188 000 USD
Key Figures INZY
1 year
3 years
5 years
10 years
EBITDA
-98 893 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-35.69 %
PEG Ratio
–
Return On Equity TTM
-79.42 %
Wall Street Target Price
19.56 USD
Revenue TTM
–
Book Value
1.29 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.55 USD
Diluted Eps TTM
-1.55 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics INZY
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History INZY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation INZY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-4.25
Price Book MRQ
2.34
Financials INZY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators INZY
For 52 weeks
2.39 USD
7.80 USD
50 Day MA
3.93 USD
Shares Short Prior Month
3 313 850
200 Day MA
4.86 USD
Short Ratio
7.59
Shares Short
3 407 026
Short Percent
5.73 %
BeatStart